The Arizona Alzheimer’s Consortium Conference, which brings together some of the nation’s top scientists and physicians to discuss advances in the fight against Alzheimer’s disease, will be held Sept. 22 at Arizona State University’s Tempe campus. The one-day...
In December 2021, the center received a $15.7 million NIH grant, which included support for the development of a pathway for students from diverse backgrounds to learn about Alzheimer’s disease research and care. Eric Reiman, MD, executive director of the Banner...
In the Artist + Researcher Exhibition, the first project to come out of the recently formed PBC Arts Committee, nine pairs of local artists and researchers from all three of the state’s public universities collaborated on visual art pieces that communicate some of the...
The drug, aducanumab, made by Biogen, would be the first new Alzheimer’s treatment in nearly two decades. But the advisory panel said there was not enough evidence of its effectiveness in slowing cognitive decline. Click here to read the full article from The New York...
Major charitable investment will offer new models of care for patients and families living with Alzheimer’s disease and other memory and thinking problems PHOENIX (September 22, 2020) – Banner Alzheimer’s Institute (BAI) has received a $10 million charitable...
Click here to register now!
OVERVIEW The Geriatric Psychiatry Fellowship at the University of Arizona College of Medicine – Phoenix strives to create an exceptional and well-trained workforce to serve the aging population in Arizona, as well as the rest of the country. The focus of the program...
Location: Tulane University | New Orleans, LAStart Date: September 2020 DESCRIPTION: A two-year postdoctoral fellow position is available at the Tulane University School of Public Health and Tropical Medicine, Department of Epidemiology. This position is with the...
A new blood test detected Alzheimer’s disease as accurately as expensive brain scans or spinal taps, raising the possibility for a new, inexpensive option to diagnose the most common form of dementia, researchers said. Read more: USA Today The New York Times...